1. Academic Validation
  2. OAT1/3 regulate the absorption of CP-25 in the rat synovium

OAT1/3 regulate the absorption of CP-25 in the rat synovium

  • Toxicol Appl Pharmacol. 2025 Jul:500:117371. doi: 10.1016/j.taap.2025.117371.
Jinzhang Gao 1 Wei Sun 1 Lei Ni 1 Qingqing Sun 1 Jiangrui Cheng 1 Ning Xiao 1 Feng Xiao 1 Wei Wei 2 Chun Wang 3
Affiliations

Affiliations

  • 1 Institute of Clinical Pharmacology, Anhui Medical University, Hefei 230032, China,; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei 230032, China.
  • 2 Institute of Clinical Pharmacology, Anhui Medical University, Hefei 230032, China,; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei 230032, China,. Electronic address: wwei@ahmu.edu.cn.
  • 3 Institute of Clinical Pharmacology, Anhui Medical University, Hefei 230032, China,; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei 230032, China,. Electronic address: wangchun@ahmu.edu.cn.
Abstract

Paeoniflorin-6'-O-benzene sulfonate (CP-25) is a new ester derivative formed by esterification of paeoniflorin. We found that CP-25 inhibits the abnormal proliferation and migration of inflammatory fibroblast-like synoviocytes (FLS). However, the mechanism by which CP-25 is absorbed by FLS remains unclear. Therefore, we established a UPLC-MS/MS methodology to study the mechanism of CP-25 uptake by FLS. Our research revealed that the uptake of CP-25 by rat FLS was time- and concentration-dependent and that the concentration of CP-25 reached a dynamic equilibrium after approximately 60 min. A glucose-free environment, a low-temperature environment or the inhibition of ATP synthesis significantly reduced the absorption of CP-25 by FLS. Furthermore, we confirmed through siRNA interference and overexpression through transient transfection that organic anion transporter (OAT)1/3 play a major role in the process of active uptake of CP-25 by FLS. Additionally, we validated the absorption of CP-25 mediated by OAT1/3 in the synovia with OAT1/3 substrates and inhibitors. Moreover, the absorption of CP-25 by FLS from Adjuvant arthritis rats and rheumatoid arthritis patients was significantly lower than that by FLS from normal rats and normal individuals. Taken together, our data suggested that CP-25 is absorbed by FLS through an active transport process, which is mediated primarily by OAT1/3. This study provides an experimental and theoretical basis for further exploration of the molecular mechanism involved.

Keywords

Absorption; CP-25; Fibroblast-like synoviocytes; UPLC–MS/MS.

Figures
Products